Abstract:Background The Pulmonary Embolism Rule-Out Criteria (PERC), developed to minimize unnecessary testing in low-risk pulmonary embolism (PE) cases, lacks clear validation in the context of COVID-19. Objectives To assess the validity of the PERC in emergency department patients having undergone computed tomography pulmonary angiography (CTPA) during the COVID-19 pandemic. Methods We conducted a retrospective analysis of emergency department patients who underwent CTPA for suspected PE. COVID-19 status was based on the results of a reverse transcription-polymerase chain reaction (RT-PCR) test performed in the emergency department, or within 30 days prior to visiting the emergency department. We collected data on demographics, symptoms, D-dimer levels, and medical history relevant to thrombosis and conducted the PERC test using the criteria including age, oxygen saturation, heart rate, and the absence of hemoptysis or recent trauma. We categorized outcomes based on the concordance between the PERC results and CTPA findings, with specific definitions for true positive and negative, as well as false positive and negative results. We also evaluated the impact of COVID-19 status on the diagnostic performance of the PERC by analyzing the prevalence of PE in patients testing positive and negative for COVID-19. Results Among the 2.430 participants, 45.1% tested negative for COVID-19, 43.4% tested positive, and 11.5% were untested. The PERC identified 91.2% of the cases as positive, 6.9% of which were confirmed to have PE. Overall, 84.9% of cases (n=2.062) showed a discordant result between the PERC and CTPA findings. The lack of significant correspondence between the PERC positivity and actual PE presence (p=0.001; p<0.01) indicated low diagnostic concordance. In patients with a positive COVID-19 test result, the PERC demonstrated a sensitivity of 95.3% (95% CI: 86.91-99.02), a specificity of 9.1% (95% CI: 7.46-11.15), a positive predictive value of 6.3% (95% CI: 6.01-6.70), a negative predictive value of 96.8% (95% CI: 90.81-98.94), and an accuracy of 14.4% (95% CI: 12.34-16.67). In patients who tested negative for COVID-19, the sensitivity was 95.4% (95% CI: 88.64-98.73), the specificity was 7.8% (95% CI: 6.25-9.66), the positive predictive value was 8.1% (95% CI: 7.83-8.57), the negative predictive value was 95.1% (95% CI: 88.11-98.14), and the accuracy was 14.7% (95% CI: 12.73-17.02). Conclusion The study demonstrates that the sensitivity and negative predictive value of the PERC are comparable in COVID-19 positive and negative patients. Furthermore, the incidence of PE among patients presenting to the emergency department did not significantly differ based on COVID-19 status. While this study highlights the relevance of the PERC in clinical decision-making, caution is advised as the PERC may not always provide reliable results when used as the sole diagnostic test.

Cardiopulmonary Complications after Pulmonary Embolism in COVID-19

Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism

Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2

Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings

COVID-19 associated pulmonary embolism: clinical, biochemical and CT imaging findings

Pulmonary embolism impacts clinical outcomes of intubated patients with acute respiratory distress syndrome related to COVID-19

Effects on Right Ventricular Function One Year after COVID-19-Related Pulmonary Embolism

Role of CT angiography in detecting acute pulmonary embolism associated with COVID-19 pneumonia

Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study

Association between pulmonary embolism and COVID-19 disease

Pulmonary embolism in patients with COVID-19 pneumonia

Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review

Pulmonary circulation abnormalities in post-acute COVID-19 syndrome: dual-energy CT angiographic findings in 79 patients

Treatment and long term follow-up results in patients with pulmonary vascular thrombosis related to COVID-19

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Risk Factors for Pulmonary Embolism in Individuals Infected with SARS-CoV2—A Single-Centre Retrospective Study

Predictive Factors of Pulmonary Embolism in Older Patients with SARS-CoV-2: The OCTA-COVID-19 Study

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium

Pulmonary Embolism Rule-out Criteria: Diagnostic Accuracy and Impact of COVID-19

Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19